Market overview
The global intrauterine devices market size was valued at USD 6.38 billion in 2023. The market is projected to grow from USD 6.59 billion in 2024 to USD 8.67 billion by 2032, exhibiting a CAGR of 3.5% during forecast period.
Intrauterine devices (IUDs), including hormonal and non-hormonal (copper) options, remain a cornerstone of long-acting reversible contraception (LARC). The global IUD market has shown steady growth in recent years driven by broader public-health initiatives, increased acceptance among reproductive-age populations, and product advances that improve ease of insertion, duration of efficacy and tolerability.
Market scope
- Product types: Hormonal IUDs (levonorgestrel-releasing systems), non-hormonal copper IUDs, and associated insertion/removal kits and ancillaries.
- Service scope: Clinical counseling and contraceptive services, public health procurement, private clinics, and post-market surveillance and training programs.
- End users: Reproductive-age women and people seeking reversible long-term contraception, adolescent programs (where permitted), and postpartum/post-abortion family planning services.
- Channels: Public procurement and health programs, private clinics and hospitals, reproductive health NGOs, and regulated retail/clinic supply chains.
Key market growth drivers
- Public-health initiatives and family-planning programs. Expanded national and NGO programs to improve contraceptive access and reduce unintended pregnancy continue to support IUD uptake, especially where training and subsidized provision are prioritized.
- Clinical education and provider training. Increased training for clinicians on counseling, correct insertion techniques and complication management reduces barriers to offering IUDs and improves user continuation rates.
- Product refinements and diversified device options. Innovations that simplify insertion, reduce device size and expand labeled duration increase acceptability among a wider age range and parity groups.
- Rising preference for long-acting, low-maintenance contraception. Patients and health systems favor methods that reduce clinic visits and improve adherence relative to short-acting methods, supporting steady demand for IUDs in both public and private sectors.
Market challenges
- Access and provider availability. In many regions, lack of trained providers and clinic capacity limits timely insertion and follow-up, constraining uptake even where demand exists.
- Cultural and informational barriers. Misconceptions, stigma and insufficient counseling about side effects or fertility recovery deter some potential users. Targeted community education is required to overcome these barriers.
- Regulatory and supply constraints. Variations in national approvals, procurement cycles and supply-chain resilience can create intermittent availability, particularly for newer device variants or smaller market segments.
- Post-market surveillance and safety monitoring. Maintaining robust adverse-event reporting systems and timely guidance for clinicians is essential as new device formats and labeling updates are introduced.
Regional analysis
North America — High rates of clinician training, integrated reproductive health services, and established private-sector channels sustain steady uptake; continuing emphasis is on expanding access to underserved populations and adolescent services
Europe — Mature public health systems and guideline-driven care support sustained use; emphasis is on ensuring access equity and addressing public concerns through transparent safety monitoring.
Asia Pacific (APAC) — Rapid absolute demand growth is driven by population scale and expanding public-health initiatives; uptake varies widely by country depending on program funding and provider training capacity.
Latin America, Middle East & Africa (LAMEA) — Mixed adoption rates: pockets of rapid expansion where family-planning programs are well funded, contrasted with regions where access and cultural barriers still limit penetration.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/intrauterine-devices-market
Key Companies in Intrauterine Devices Market
- Bayer AG
- CooperSurgical Inc.
- DKT International
- Egemen International
- HLL Lifecare Limited
- Medisafe Distribution Inc.
- Meril Life Sciences Pvt. Ltd.
- OCON Medical Ltd.
- Pregna International Limited
- Prosan International BV
- SMB Corporation
- The Cooper Companies Inc.
- Mona Lisa NV
- Sebela Pharmaceuticals
- Medicines360
Conclusion
The Intrauterine Devices market remains a durable segment of global reproductive health, balancing stable demand in mature markets with high growth potential in regions expanding family-planning services. Overcoming provider shortages, misinformation and supply constraints will unlock additional uptake. Stakeholders that invest in provider training, community education and resilient procurement channels will play a central role in translating unmet need into sustained, equitable access to IUDs.
More Trending Latest Reports By Polaris Market Research:
Aerospace Parts Manufacturing Market - update
Audio and Visual Public Addressal System Market
Aircraft Engine Exhaust Market
Audio and Visual Public Addressal System Market
Automotive Powertrain Systems Market
Heat Shrink Tubing and Sleeves Market
Percutaneous Coronary Intervention (Pci) Devices Market
Heat Shrink Tubing and Sleeves Market
Purified Terephthalic Acid (PTA) Market
